MDB Capital Holdings (MDBH) Q3 2025 earnings summary

Executive summary

• Platform and pipeline have shown strong progress, aiming to scale launches from one every 18 months to three to five per year, with a 28-year track record and 100% IPO success rate, and all IPOs trading at a premium post-launch.

• Largest shareholders are committed to value creation, aligning interests with entrepreneurs and investors.

• Operates two main segments: broker dealer & intellectual property services, and technology development, with a shift in 2025 after deconsolidating eXoZymes post-IPO.

• Anticipates closing a $16.8 million private placement for Paulex Bio and a $20 million IPO for Buda Juice, while expanding its pipeline of early-stage, disruptive companies and investor base.

• Community-driven sourcing and support are critical to the business model and operational scaling.

Financial highlights

• Operating expenses for the first three quarters totaled $5.9 million, with net cash used in operational activities at $5.9 million through the first three quarters of 2025.

• For the nine months ended September 30, 2025, net loss attributable to members was $19.5M, with total operating income of $179K, down from $1.0M year-over-year, mainly due to a $2.4M unrealized loss on investment securities.

• General and administrative costs decreased 20% year-over-year to $17.2M, reflecting lower compensation and professional fees.

• Cash and cash equivalents at September 30, 2025, were $15.1M, down from $20.4M at year-end 2024.

• Anticipated closings of Paulex Bio private placement ($16.8M) and Buda Juice IPO ($20M) expected to generate positive cash and add to equity holdings.

Outlook and guidance

• Targeting three to five launches in the next year, with four to five more in late-stage negotiations and a belief that each has a higher probability of success than historical launches.

• Management is monitoring macroeconomic risks, including potential recession and government policy changes, and may adjust business and financing plans as needed.

• Expects a resurgence in the MicroCap market, driven by demand for transparency and liquidity.

• No specific forward-looking financial guidance provided.

• Management expresses confidence in scaling the public venture platform and creating a diversified portfolio with asymmetric upside potential.